Overview
Thymogen is a synthetic dipeptide (Glu-Trp) bioregulator derived from the thymus and representing another member of the Khavinson peptide family. It combines glutamic acid and tryptophan to provide immunomodulatory effects primarily targeting T-lymphocyte function. Research suggests it modulates T-cell differentiation, balances cytokine profiles, and may have applications in immune deficiency states associated with aging, chronic illness, or post-chemotherapy recovery.
Mechanism of Action
Thymogen (Glu-Trp) acts as a chromatin-modulating dipeptide similar to Vilon, interacting with DNA-associated proteins to regulate gene expression in immune cells. It influences T-helper cell polarization and cytokine production, potentially through NF-κB pathway modulation similar to other Khavinson peptides. The tryptophan component may additionally influence serotonin and kynurenine pathways that modulate immune tolerance and inflammation.
Potential Benefits
- T-lymphocyte function modulation
- Cytokine balance improvement in immunodeficiency
- Potential recovery support post-chemotherapy
- Anti-inflammatory effects via NF-κB pathway modulation
- Thymus function support in aging
Research Dosage Notes
The following reflects doses used in published research studies. This is not medical advice.
Typical oral protocols: 10 mg/day for 30-day cycles, 2-3 times/year. Can be combined with other Khavinson peptides.
Amino Acid Sequence
Glu-Trp
Side Effects & Safety
- Generally well-tolerated
- Minimal reported adverse effects
Synergistic Compounds
The following compounds have been studied alongside Thymogen for potential complementary or synergistic effects:
Learn More
References & Further Reading
- [object Object]